There seem to be a kind of superiority of PROTACs over conventional inhibitors in treating prostate cancer. The article examines various targets for PROTACs in prostate cancer, including the androgen receptor and other critical oncoproteins, while addressing future prospects and challenges in this field.
Proteolysis-Targeting Chimeras (PROTA... - Advanced Prostate...
Proteolysis-Targeting Chimeras (PROTACs): targeting cancer by deleting deleterious proteins?
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
They're joshing......
Good Luck, Good Health and Good Humor.
j-o-h-n Sunday 12/03/2023 6:14 PM EST
Not what you're looking for?
You may also like...
Killing Prostate Cancer With Diet
across this article using AI.
https://easyhealthoptions.com/12-natural-prostate-cancer-killers/
Repurposed drugs for Prostate Cancer
Article from NIH on repurposing drugs for Prostate Cancer
https://www.mdpi.com/2146836
Magnus
PROTAC -- new class of drug - first trial for prostate cancer
to begin by mid-2019, will include 28–36 men with metastatic prostate cancer and will last around 9...
\"Researchers Develop New Strategy to Target Breast Cancer Metastasis in Bones\"
I wonder if this could work for prostate cancer bone mets, including those who have already had...
Nexrutine and Prostate Cancer
PI5P4Kα - targeting single enzyme kills prostate cancer?
New approach for advanced metastatic prostate cancer sufferers:
